nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitomycin—Alkylating Activity—Thiotepa—sarcoma	0.431	0.556	CiPCiCtD
Mitomycin—Alkylating Activity—Dacarbazine—sarcoma	0.345	0.444	CiPCiCtD
Mitomycin—POR—Doxorubicin—sarcoma	0.113	0.63	CbGbCtD
Mitomycin—ABCB1—Dactinomycin—sarcoma	0.0192	0.107	CbGbCtD
Mitomycin—ABCB1—Mitoxantrone—sarcoma	0.0172	0.0958	CbGbCtD
Mitomycin—ABCB1—Vincristine—sarcoma	0.0118	0.0659	CbGbCtD
Mitomycin—ABCB1—Etoposide—sarcoma	0.0108	0.0604	CbGbCtD
Mitomycin—ABCB1—Doxorubicin—sarcoma	0.00739	0.0412	CbGbCtD
Mitomycin—Myelosuppression—Vincristine—sarcoma	0.000793	0.0176	CcSEcCtD
Mitomycin—Myelosuppression—Mitoxantrone—sarcoma	0.000772	0.0171	CcSEcCtD
Mitomycin—Cardiotoxicity—Epirubicin—sarcoma	0.000717	0.0159	CcSEcCtD
Mitomycin—Cardiotoxicity—Doxorubicin—sarcoma	0.000663	0.0147	CcSEcCtD
Mitomycin—Myelosuppression—Etoposide—sarcoma	0.000642	0.0142	CcSEcCtD
Mitomycin—Nephropathy toxic—Mitoxantrone—sarcoma	0.000631	0.014	CcSEcCtD
Mitomycin—Necrosis—Dactinomycin—sarcoma	0.00053	0.0118	CcSEcCtD
Mitomycin—Nephropathy toxic—Etoposide—sarcoma	0.000525	0.0116	CcSEcCtD
Mitomycin—Extravasation—Thiotepa—sarcoma	0.000481	0.0107	CcSEcCtD
Mitomycin—Extravasation—Dactinomycin—sarcoma	0.000477	0.0106	CcSEcCtD
Mitomycin—Necrosis—Mitoxantrone—sarcoma	0.000461	0.0102	CcSEcCtD
Mitomycin—Ulcer—Dactinomycin—sarcoma	0.00044	0.00976	CcSEcCtD
Mitomycin—Extravasation—Vincristine—sarcoma	0.000426	0.00945	CcSEcCtD
Mitomycin—Extravasation—Mitoxantrone—sarcoma	0.000415	0.0092	CcSEcCtD
Mitomycin—Necrosis—Etoposide—sarcoma	0.000384	0.00851	CcSEcCtD
Mitomycin—Ulcer—Mitoxantrone—sarcoma	0.000383	0.00849	CcSEcCtD
Mitomycin—Pulmonary oedema—Thiotepa—sarcoma	0.000373	0.00828	CcSEcCtD
Mitomycin—Myelosuppression—Epirubicin—sarcoma	0.00036	0.00798	CcSEcCtD
Mitomycin—Extravasation—Etoposide—sarcoma	0.000345	0.00765	CcSEcCtD
Mitomycin—Myelosuppression—Doxorubicin—sarcoma	0.000333	0.00739	CcSEcCtD
Mitomycin—Ulcer—Etoposide—sarcoma	0.000319	0.00706	CcSEcCtD
Mitomycin—Cardiac failure congestive—Mitoxantrone—sarcoma	0.00029	0.00643	CcSEcCtD
Mitomycin—Pancytopenia—Thiotepa—sarcoma	0.00025	0.00554	CcSEcCtD
Mitomycin—Pancytopenia—Dactinomycin—sarcoma	0.000248	0.0055	CcSEcCtD
Mitomycin—Haematemesis—Epirubicin—sarcoma	0.000243	0.00539	CcSEcCtD
Mitomycin—Burning sensation—Epirubicin—sarcoma	0.000243	0.00539	CcSEcCtD
Mitomycin—Cardiac failure congestive—Etoposide—sarcoma	0.000241	0.00535	CcSEcCtD
Mitomycin—Renal failure—Thiotepa—sarcoma	0.000231	0.00511	CcSEcCtD
Mitomycin—Stomatitis—Thiotepa—sarcoma	0.000229	0.00507	CcSEcCtD
Mitomycin—Stomatitis—Dactinomycin—sarcoma	0.000227	0.00503	CcSEcCtD
Mitomycin—Haematemesis—Doxorubicin—sarcoma	0.000225	0.00499	CcSEcCtD
Mitomycin—Burning sensation—Doxorubicin—sarcoma	0.000225	0.00499	CcSEcCtD
Mitomycin—Pancytopenia—Vincristine—sarcoma	0.000222	0.00491	CcSEcCtD
Mitomycin—Pancytopenia—Mitoxantrone—sarcoma	0.000216	0.00478	CcSEcCtD
Mitomycin—Necrosis—Epirubicin—sarcoma	0.000215	0.00477	CcSEcCtD
Mitomycin—Stinging—Epirubicin—sarcoma	0.000208	0.00462	CcSEcCtD
Mitomycin—Stomatitis—Vincristine—sarcoma	0.000203	0.0045	CcSEcCtD
Mitomycin—Drowsiness—Mitoxantrone—sarcoma	0.000203	0.00449	CcSEcCtD
Mitomycin—Renal failure—Mitoxantrone—sarcoma	0.000199	0.00442	CcSEcCtD
Mitomycin—Necrosis—Doxorubicin—sarcoma	0.000199	0.00441	CcSEcCtD
Mitomycin—Stomatitis—Mitoxantrone—sarcoma	0.000197	0.00438	CcSEcCtD
Mitomycin—Extravasation—Epirubicin—sarcoma	0.000194	0.00429	CcSEcCtD
Mitomycin—Stinging—Doxorubicin—sarcoma	0.000193	0.00428	CcSEcCtD
Mitomycin—Alopecia—Thiotepa—sarcoma	0.000186	0.00413	CcSEcCtD
Mitomycin—Alopecia—Dactinomycin—sarcoma	0.000185	0.00409	CcSEcCtD
Mitomycin—Erythema—Thiotepa—sarcoma	0.000183	0.00406	CcSEcCtD
Mitomycin—Erythema—Dactinomycin—sarcoma	0.000182	0.00403	CcSEcCtD
Mitomycin—Pancytopenia—Etoposide—sarcoma	0.000179	0.00398	CcSEcCtD
Mitomycin—Extravasation—Doxorubicin—sarcoma	0.000179	0.00397	CcSEcCtD
Mitomycin—Ulcer—Epirubicin—sarcoma	0.000179	0.00396	CcSEcCtD
Mitomycin—Vision blurred—Thiotepa—sarcoma	0.000173	0.00383	CcSEcCtD
Mitomycin—Anaemia—Thiotepa—sarcoma	0.000169	0.00376	CcSEcCtD
Mitomycin—Ill-defined disorder—Dactinomycin—sarcoma	0.000169	0.00374	CcSEcCtD
Mitomycin—Anaemia—Dactinomycin—sarcoma	0.000168	0.00373	CcSEcCtD
Mitomycin—Injection site reaction—Epirubicin—sarcoma	0.000168	0.00372	CcSEcCtD
Mitomycin—Renal failure—Etoposide—sarcoma	0.000166	0.00367	CcSEcCtD
Mitomycin—Ulcer—Doxorubicin—sarcoma	0.000165	0.00366	CcSEcCtD
Mitomycin—Alopecia—Vincristine—sarcoma	0.000165	0.00366	CcSEcCtD
Mitomycin—Stomatitis—Etoposide—sarcoma	0.000164	0.00364	CcSEcCtD
Mitomycin—Leukopenia—Thiotepa—sarcoma	0.000164	0.00364	CcSEcCtD
Mitomycin—Malaise—Dactinomycin—sarcoma	0.000164	0.00364	CcSEcCtD
Mitomycin—Leukopenia—Dactinomycin—sarcoma	0.000163	0.00361	CcSEcCtD
Mitomycin—Alopecia—Mitoxantrone—sarcoma	0.000161	0.00356	CcSEcCtD
Mitomycin—Cough—Thiotepa—sarcoma	0.00016	0.00355	CcSEcCtD
Mitomycin—Erythema—Mitoxantrone—sarcoma	0.000158	0.00351	CcSEcCtD
Mitomycin—Hypertension—Thiotepa—sarcoma	0.000158	0.00351	CcSEcCtD
Mitomycin—Injection site reaction—Doxorubicin—sarcoma	0.000155	0.00344	CcSEcCtD
Mitomycin—Discomfort—Dactinomycin—sarcoma	0.000153	0.00339	CcSEcCtD
Mitomycin—Confusional state—Thiotepa—sarcoma	0.000151	0.00334	CcSEcCtD
Mitomycin—Pulmonary oedema—Epirubicin—sarcoma	0.00015	0.00333	CcSEcCtD
Mitomycin—Anaemia—Vincristine—sarcoma	0.00015	0.00333	CcSEcCtD
Mitomycin—Vision blurred—Mitoxantrone—sarcoma	0.000149	0.00331	CcSEcCtD
Mitomycin—Oedema—Dactinomycin—sarcoma	0.000149	0.00329	CcSEcCtD
Mitomycin—Ill-defined disorder—Mitoxantrone—sarcoma	0.000147	0.00326	CcSEcCtD
Mitomycin—Thrombocytopenia—Thiotepa—sarcoma	0.000147	0.00325	CcSEcCtD
Mitomycin—Anaemia—Mitoxantrone—sarcoma	0.000146	0.00324	CcSEcCtD
Mitomycin—Leukopenia—Vincristine—sarcoma	0.000146	0.00323	CcSEcCtD
Mitomycin—Thrombocytopenia—Dactinomycin—sarcoma	0.000145	0.00322	CcSEcCtD
Mitomycin—Malaise—Mitoxantrone—sarcoma	0.000143	0.00317	CcSEcCtD
Mitomycin—Anorexia—Thiotepa—sarcoma	0.000143	0.00316	CcSEcCtD
Mitomycin—Leukopenia—Mitoxantrone—sarcoma	0.000142	0.00314	CcSEcCtD
Mitomycin—Thrombophlebitis—Epirubicin—sarcoma	0.000142	0.00314	CcSEcCtD
Mitomycin—Anorexia—Dactinomycin—sarcoma	0.000142	0.00314	CcSEcCtD
Mitomycin—Hypertension—Vincristine—sarcoma	0.00014	0.00311	CcSEcCtD
Mitomycin—Pulmonary oedema—Doxorubicin—sarcoma	0.000139	0.00308	CcSEcCtD
Mitomycin—Cough—Mitoxantrone—sarcoma	0.000138	0.00306	CcSEcCtD
Mitomycin—Hypertension—Mitoxantrone—sarcoma	0.000137	0.00303	CcSEcCtD
Mitomycin—Cardiac failure congestive—Epirubicin—sarcoma	0.000135	0.003	CcSEcCtD
Mitomycin—Alopecia—Etoposide—sarcoma	0.000134	0.00296	CcSEcCtD
Mitomycin—Discomfort—Mitoxantrone—sarcoma	0.000133	0.00295	CcSEcCtD
Mitomycin—Somnolence—Thiotepa—sarcoma	0.000133	0.00295	CcSEcCtD
Mitomycin—Oedema—Vincristine—sarcoma	0.000133	0.00294	CcSEcCtD
Mitomycin—Thrombophlebitis—Doxorubicin—sarcoma	0.000131	0.0029	CcSEcCtD
Mitomycin—Confusional state—Mitoxantrone—sarcoma	0.00013	0.00289	CcSEcCtD
Mitomycin—Decreased appetite—Thiotepa—sarcoma	0.00013	0.00288	CcSEcCtD
Mitomycin—Thrombocytopenia—Vincristine—sarcoma	0.00013	0.00288	CcSEcCtD
Mitomycin—Oedema—Mitoxantrone—sarcoma	0.000129	0.00286	CcSEcCtD
Mitomycin—Decreased appetite—Dactinomycin—sarcoma	0.000129	0.00286	CcSEcCtD
Mitomycin—Fatigue—Thiotepa—sarcoma	0.000129	0.00286	CcSEcCtD
Mitomycin—Renal impairment—Epirubicin—sarcoma	0.000129	0.00286	CcSEcCtD
Mitomycin—Fatigue—Dactinomycin—sarcoma	0.000128	0.00284	CcSEcCtD
Mitomycin—Pain—Thiotepa—sarcoma	0.000128	0.00284	CcSEcCtD
Mitomycin—Shock—Mitoxantrone—sarcoma	0.000127	0.00282	CcSEcCtD
Mitomycin—Pain—Dactinomycin—sarcoma	0.000127	0.00282	CcSEcCtD
Mitomycin—Thrombocytopenia—Mitoxantrone—sarcoma	0.000127	0.0028	CcSEcCtD
Mitomycin—Anorexia—Vincristine—sarcoma	0.000126	0.0028	CcSEcCtD
Mitomycin—Cardiac failure congestive—Doxorubicin—sarcoma	0.000125	0.00277	CcSEcCtD
Mitomycin—Feeling abnormal—Thiotepa—sarcoma	0.000123	0.00273	CcSEcCtD
Mitomycin—Anorexia—Mitoxantrone—sarcoma	0.000123	0.00273	CcSEcCtD
Mitomycin—Feeling abnormal—Dactinomycin—sarcoma	0.000122	0.00271	CcSEcCtD
Mitomycin—Ill-defined disorder—Etoposide—sarcoma	0.000122	0.00271	CcSEcCtD
Mitomycin—Anaemia—Etoposide—sarcoma	0.000122	0.0027	CcSEcCtD
Mitomycin—Renal impairment—Doxorubicin—sarcoma	0.000119	0.00264	CcSEcCtD
Mitomycin—Malaise—Etoposide—sarcoma	0.000119	0.00263	CcSEcCtD
Mitomycin—Body temperature increased—Thiotepa—sarcoma	0.000118	0.00262	CcSEcCtD
Mitomycin—Leukopenia—Etoposide—sarcoma	0.000118	0.00261	CcSEcCtD
Mitomycin—Body temperature increased—Dactinomycin—sarcoma	0.000117	0.0026	CcSEcCtD
Mitomycin—Loss of consciousness—Etoposide—sarcoma	0.000116	0.00257	CcSEcCtD
Mitomycin—Decreased appetite—Vincristine—sarcoma	0.000115	0.00256	CcSEcCtD
Mitomycin—Dyspnoea—Mitoxantrone—sarcoma	0.000115	0.00255	CcSEcCtD
Mitomycin—Cough—Etoposide—sarcoma	0.000115	0.00255	CcSEcCtD
Mitomycin—Somnolence—Mitoxantrone—sarcoma	0.000115	0.00255	CcSEcCtD
Mitomycin—Fatigue—Vincristine—sarcoma	0.000114	0.00254	CcSEcCtD
Mitomycin—Hypertension—Etoposide—sarcoma	0.000114	0.00252	CcSEcCtD
Mitomycin—Pain—Vincristine—sarcoma	0.000113	0.00252	CcSEcCtD
Mitomycin—Decreased appetite—Mitoxantrone—sarcoma	0.000112	0.00249	CcSEcCtD
Mitomycin—Fatigue—Mitoxantrone—sarcoma	0.000111	0.00247	CcSEcCtD
Mitomycin—Discomfort—Etoposide—sarcoma	0.000111	0.00246	CcSEcCtD
Mitomycin—Pain—Mitoxantrone—sarcoma	0.000111	0.00245	CcSEcCtD
Mitomycin—Confusional state—Etoposide—sarcoma	0.000108	0.0024	CcSEcCtD
Mitomycin—Asthenia—Thiotepa—sarcoma	0.000107	0.00238	CcSEcCtD
Mitomycin—Asthenia—Dactinomycin—sarcoma	0.000107	0.00236	CcSEcCtD
Mitomycin—Feeling abnormal—Mitoxantrone—sarcoma	0.000106	0.00236	CcSEcCtD
Mitomycin—Thrombocytopenia—Etoposide—sarcoma	0.000105	0.00233	CcSEcCtD
Mitomycin—Body temperature increased—Vincristine—sarcoma	0.000105	0.00233	CcSEcCtD
Mitomycin—Anorexia—Etoposide—sarcoma	0.000102	0.00227	CcSEcCtD
Mitomycin—Diarrhoea—Thiotepa—sarcoma	0.000102	0.00227	CcSEcCtD
Mitomycin—Body temperature increased—Mitoxantrone—sarcoma	0.000102	0.00226	CcSEcCtD
Mitomycin—Diarrhoea—Dactinomycin—sarcoma	0.000102	0.00225	CcSEcCtD
Mitomycin—Pancytopenia—Epirubicin—sarcoma	0.000101	0.00223	CcSEcCtD
Mitomycin—Dizziness—Thiotepa—sarcoma	9.89e-05	0.00219	CcSEcCtD
Mitomycin—Dyspnoea—Etoposide—sarcoma	9.58e-05	0.00212	CcSEcCtD
Mitomycin—Somnolence—Etoposide—sarcoma	9.56e-05	0.00212	CcSEcCtD
Mitomycin—Asthenia—Vincristine—sarcoma	9.52e-05	0.00211	CcSEcCtD
Mitomycin—Vomiting—Thiotepa—sarcoma	9.51e-05	0.00211	CcSEcCtD
Mitomycin—Drowsiness—Epirubicin—sarcoma	9.45e-05	0.00209	CcSEcCtD
Mitomycin—Vomiting—Dactinomycin—sarcoma	9.44e-05	0.00209	CcSEcCtD
Mitomycin—Rash—Thiotepa—sarcoma	9.43e-05	0.00209	CcSEcCtD
Mitomycin—Dermatitis—Thiotepa—sarcoma	9.43e-05	0.00209	CcSEcCtD
Mitomycin—Headache—Thiotepa—sarcoma	9.37e-05	0.00208	CcSEcCtD
Mitomycin—Rash—Dactinomycin—sarcoma	9.36e-05	0.00208	CcSEcCtD
Mitomycin—Decreased appetite—Etoposide—sarcoma	9.34e-05	0.00207	CcSEcCtD
Mitomycin—Pancytopenia—Doxorubicin—sarcoma	9.31e-05	0.00206	CcSEcCtD
Mitomycin—Renal failure—Epirubicin—sarcoma	9.29e-05	0.00206	CcSEcCtD
Mitomycin—Asthenia—Mitoxantrone—sarcoma	9.27e-05	0.00206	CcSEcCtD
Mitomycin—Fatigue—Etoposide—sarcoma	9.27e-05	0.00205	CcSEcCtD
Mitomycin—Stomatitis—Epirubicin—sarcoma	9.21e-05	0.00204	CcSEcCtD
Mitomycin—Pain—Etoposide—sarcoma	9.19e-05	0.00204	CcSEcCtD
Mitomycin—Diarrhoea—Vincristine—sarcoma	9.08e-05	0.00201	CcSEcCtD
Mitomycin—Nausea—Thiotepa—sarcoma	8.89e-05	0.00197	CcSEcCtD
Mitomycin—Feeling abnormal—Etoposide—sarcoma	8.86e-05	0.00196	CcSEcCtD
Mitomycin—Diarrhoea—Mitoxantrone—sarcoma	8.84e-05	0.00196	CcSEcCtD
Mitomycin—Nausea—Dactinomycin—sarcoma	8.82e-05	0.00196	CcSEcCtD
Mitomycin—Dizziness—Vincristine—sarcoma	8.77e-05	0.00195	CcSEcCtD
Mitomycin—Drowsiness—Doxorubicin—sarcoma	8.74e-05	0.00194	CcSEcCtD
Mitomycin—Renal failure—Doxorubicin—sarcoma	8.59e-05	0.0019	CcSEcCtD
Mitomycin—Stomatitis—Doxorubicin—sarcoma	8.52e-05	0.00189	CcSEcCtD
Mitomycin—Body temperature increased—Etoposide—sarcoma	8.5e-05	0.00188	CcSEcCtD
Mitomycin—Vomiting—Vincristine—sarcoma	8.44e-05	0.00187	CcSEcCtD
Mitomycin—Rash—Vincristine—sarcoma	8.37e-05	0.00185	CcSEcCtD
Mitomycin—Dermatitis—Vincristine—sarcoma	8.36e-05	0.00185	CcSEcCtD
Mitomycin—Headache—Vincristine—sarcoma	8.31e-05	0.00184	CcSEcCtD
Mitomycin—Vomiting—Mitoxantrone—sarcoma	8.22e-05	0.00182	CcSEcCtD
Mitomycin—Rash—Mitoxantrone—sarcoma	8.15e-05	0.00181	CcSEcCtD
Mitomycin—Dermatitis—Mitoxantrone—sarcoma	8.14e-05	0.0018	CcSEcCtD
Mitomycin—Headache—Mitoxantrone—sarcoma	8.1e-05	0.00179	CcSEcCtD
Mitomycin—Nausea—Vincristine—sarcoma	7.88e-05	0.00175	CcSEcCtD
Mitomycin—Asthenia—Etoposide—sarcoma	7.71e-05	0.00171	CcSEcCtD
Mitomycin—Nausea—Mitoxantrone—sarcoma	7.68e-05	0.0017	CcSEcCtD
Mitomycin—Alopecia—Epirubicin—sarcoma	7.49e-05	0.00166	CcSEcCtD
Mitomycin—Erythema—Epirubicin—sarcoma	7.38e-05	0.00164	CcSEcCtD
Mitomycin—Diarrhoea—Etoposide—sarcoma	7.35e-05	0.00163	CcSEcCtD
Mitomycin—Dizziness—Etoposide—sarcoma	7.11e-05	0.00158	CcSEcCtD
Mitomycin—Vision blurred—Epirubicin—sarcoma	6.96e-05	0.00154	CcSEcCtD
Mitomycin—Alopecia—Doxorubicin—sarcoma	6.93e-05	0.00154	CcSEcCtD
Mitomycin—Ill-defined disorder—Epirubicin—sarcoma	6.85e-05	0.00152	CcSEcCtD
Mitomycin—Vomiting—Etoposide—sarcoma	6.83e-05	0.00151	CcSEcCtD
Mitomycin—Erythema—Doxorubicin—sarcoma	6.83e-05	0.00151	CcSEcCtD
Mitomycin—Anaemia—Epirubicin—sarcoma	6.82e-05	0.00151	CcSEcCtD
Mitomycin—Rash—Etoposide—sarcoma	6.78e-05	0.0015	CcSEcCtD
Mitomycin—Dermatitis—Etoposide—sarcoma	6.77e-05	0.0015	CcSEcCtD
Mitomycin—Headache—Etoposide—sarcoma	6.73e-05	0.00149	CcSEcCtD
Mitomycin—Malaise—Epirubicin—sarcoma	6.66e-05	0.00148	CcSEcCtD
Mitomycin—Syncope—Epirubicin—sarcoma	6.62e-05	0.00147	CcSEcCtD
Mitomycin—Leukopenia—Epirubicin—sarcoma	6.61e-05	0.00146	CcSEcCtD
Mitomycin—Loss of consciousness—Epirubicin—sarcoma	6.49e-05	0.00144	CcSEcCtD
Mitomycin—Cough—Epirubicin—sarcoma	6.44e-05	0.00143	CcSEcCtD
Mitomycin—Vision blurred—Doxorubicin—sarcoma	6.44e-05	0.00143	CcSEcCtD
Mitomycin—Nausea—Etoposide—sarcoma	6.38e-05	0.00142	CcSEcCtD
Mitomycin—Hypertension—Epirubicin—sarcoma	6.37e-05	0.00141	CcSEcCtD
Mitomycin—Ill-defined disorder—Doxorubicin—sarcoma	6.34e-05	0.00141	CcSEcCtD
Mitomycin—Anaemia—Doxorubicin—sarcoma	6.31e-05	0.0014	CcSEcCtD
Mitomycin—Discomfort—Epirubicin—sarcoma	6.21e-05	0.00138	CcSEcCtD
Mitomycin—Malaise—Doxorubicin—sarcoma	6.16e-05	0.00137	CcSEcCtD
Mitomycin—Syncope—Doxorubicin—sarcoma	6.13e-05	0.00136	CcSEcCtD
Mitomycin—Leukopenia—Doxorubicin—sarcoma	6.11e-05	0.00136	CcSEcCtD
Mitomycin—Confusional state—Epirubicin—sarcoma	6.08e-05	0.00135	CcSEcCtD
Mitomycin—Oedema—Epirubicin—sarcoma	6.03e-05	0.00134	CcSEcCtD
Mitomycin—Loss of consciousness—Doxorubicin—sarcoma	6e-05	0.00133	CcSEcCtD
Mitomycin—Cough—Doxorubicin—sarcoma	5.96e-05	0.00132	CcSEcCtD
Mitomycin—Shock—Epirubicin—sarcoma	5.93e-05	0.00131	CcSEcCtD
Mitomycin—Thrombocytopenia—Epirubicin—sarcoma	5.9e-05	0.00131	CcSEcCtD
Mitomycin—Hypertension—Doxorubicin—sarcoma	5.9e-05	0.00131	CcSEcCtD
Mitomycin—Discomfort—Doxorubicin—sarcoma	5.75e-05	0.00127	CcSEcCtD
Mitomycin—Anorexia—Epirubicin—sarcoma	5.74e-05	0.00127	CcSEcCtD
Mitomycin—Confusional state—Doxorubicin—sarcoma	5.62e-05	0.00125	CcSEcCtD
Mitomycin—Oedema—Doxorubicin—sarcoma	5.57e-05	0.00124	CcSEcCtD
Mitomycin—Shock—Doxorubicin—sarcoma	5.48e-05	0.00122	CcSEcCtD
Mitomycin—Thrombocytopenia—Doxorubicin—sarcoma	5.46e-05	0.00121	CcSEcCtD
Mitomycin—Dyspnoea—Epirubicin—sarcoma	5.37e-05	0.00119	CcSEcCtD
Mitomycin—Somnolence—Epirubicin—sarcoma	5.36e-05	0.00119	CcSEcCtD
Mitomycin—Anorexia—Doxorubicin—sarcoma	5.31e-05	0.00118	CcSEcCtD
Mitomycin—Decreased appetite—Epirubicin—sarcoma	5.24e-05	0.00116	CcSEcCtD
Mitomycin—Fatigue—Epirubicin—sarcoma	5.19e-05	0.00115	CcSEcCtD
Mitomycin—Pain—Epirubicin—sarcoma	5.15e-05	0.00114	CcSEcCtD
Mitomycin—Dyspnoea—Doxorubicin—sarcoma	4.97e-05	0.0011	CcSEcCtD
Mitomycin—Feeling abnormal—Epirubicin—sarcoma	4.96e-05	0.0011	CcSEcCtD
Mitomycin—Somnolence—Doxorubicin—sarcoma	4.96e-05	0.0011	CcSEcCtD
Mitomycin—Decreased appetite—Doxorubicin—sarcoma	4.85e-05	0.00107	CcSEcCtD
Mitomycin—Fatigue—Doxorubicin—sarcoma	4.81e-05	0.00107	CcSEcCtD
Mitomycin—Pain—Doxorubicin—sarcoma	4.77e-05	0.00106	CcSEcCtD
Mitomycin—Body temperature increased—Epirubicin—sarcoma	4.76e-05	0.00106	CcSEcCtD
Mitomycin—Feeling abnormal—Doxorubicin—sarcoma	4.59e-05	0.00102	CcSEcCtD
Mitomycin—Body temperature increased—Doxorubicin—sarcoma	4.41e-05	0.000977	CcSEcCtD
Mitomycin—Asthenia—Epirubicin—sarcoma	4.32e-05	0.000958	CcSEcCtD
Mitomycin—Diarrhoea—Epirubicin—sarcoma	4.12e-05	0.000914	CcSEcCtD
Mitomycin—Asthenia—Doxorubicin—sarcoma	4e-05	0.000887	CcSEcCtD
Mitomycin—Dizziness—Epirubicin—sarcoma	3.98e-05	0.000883	CcSEcCtD
Mitomycin—Vomiting—Epirubicin—sarcoma	3.83e-05	0.000849	CcSEcCtD
Mitomycin—Diarrhoea—Doxorubicin—sarcoma	3.81e-05	0.000846	CcSEcCtD
Mitomycin—Rash—Epirubicin—sarcoma	3.8e-05	0.000842	CcSEcCtD
Mitomycin—Dermatitis—Epirubicin—sarcoma	3.8e-05	0.000841	CcSEcCtD
Mitomycin—Headache—Epirubicin—sarcoma	3.77e-05	0.000837	CcSEcCtD
Mitomycin—Dizziness—Doxorubicin—sarcoma	3.69e-05	0.000817	CcSEcCtD
Mitomycin—Nausea—Epirubicin—sarcoma	3.58e-05	0.000793	CcSEcCtD
Mitomycin—Vomiting—Doxorubicin—sarcoma	3.54e-05	0.000786	CcSEcCtD
Mitomycin—Rash—Doxorubicin—sarcoma	3.52e-05	0.000779	CcSEcCtD
Mitomycin—Dermatitis—Doxorubicin—sarcoma	3.51e-05	0.000779	CcSEcCtD
Mitomycin—Headache—Doxorubicin—sarcoma	3.49e-05	0.000774	CcSEcCtD
Mitomycin—Nausea—Doxorubicin—sarcoma	3.31e-05	0.000734	CcSEcCtD
